Stocks were up very slightly on Monday morning, but not enough to offset Friday’s sell-off after the Clinton email situation was brought back front and center. The earnings floodgates are open wide, and this week will mark the apex of earnings season. Investors keep proving over and over that they will buy each pullback. High valuations and a bull market that is seven and a half years old have not prevented buyers from stepping in. Investors are also looking for new ideas to generate gains or income ahead.
24/7 Wall St. reviews dozens of analyst research reports each morning of the week to find new investing and trading ideas for our readers. Some of these analyst research reports cover stocks to buy, and other calls cover stocks to sell or avoid.
These are the top analyst upgrades, downgrades and initiations seen on Monday morning:
AbbVie Inc. (NYSE: ABBV) was downgraded to Neutral from Outperform and the price target was cut to $60 from $70 (versus a $57.60 prior close) at Credit Suisse. The stock has a 52-week trading range of $50.71 to $68.12 and a consensus analyst price target of $70.63.
Chevron Corp. (NYSE: CVX) was raised to Buy from Neutral and was added to the prized Conviction Buy list with a $118 price target (versus a $103.82 close) at Goldman Sachs. Jefferies reiterated its Buy rating and raised its target to $120 from $116. The 52-week range is $75.33 to $107.58, and the consensus price target is $111.71.
Home Depot Inc. (NYSE: HD) was downgraded to Neutral from Overweight and the price target was cut to $121 from $152 (versus a $123.58 close) at Piper Jaffray. The 52-week range is $109.62 to $139.00, and the consensus analyst target is $149.87.
Nike Inc. (NYSE: NKE) was downgraded to Underperform from Neutral with a $46 price target (versus a$52.02 close) at Merrill Lynch. The 52-week range is $50.71 to $68.19. The consensus price target is $62.41.
Qualcomm Inc. (NASDAQ: QCOM) was raised to Buy from Neutral and the price target was raised to $80 from $55 (versus a $68.40 close) at Nomura. It has a 52-week range of $42.24 to $71.62 and a consensus price target of $70.15.
VMware Inc. (NYSE: VMW) was raised to Outperform from Perform with a $90 price target (versus a $77.65 close) at Oppenheimer. The 52-week range is $43.25 to $77.98, and the consensus price target is $78.86.
You can follow @Jonogg on Twitter if you want the daily analyst calls and research updates directly on your Twitter feed.
Other key analyst upgrades and downgrades were seen as follows: